Therapeutic and diagnostic implications of the somatostatin system in gastroenteropancreatic neuroendocrine tumour disease

Italian Journal of Gastroenterology and Hepatology

Volumn 31, Issue 7 SUPPL. 2, 1999, Pages

  Hocker M ^a   Wiedenmann, B ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Neuroendocrine tumours; Octreotide; Somatostatin; Somatostatin biotherapy; Somatostatin receptor scintigraphy; Somatostatin receptors

Indexed keywords

ADENYLATE CYCLASE; ANGIOPEPTIN; EPIDERMAL GROWTH FACTOR RECEPTOR; HYPOTHALAMUS RELEASE INHIBITING FACTOR; MITOGEN ACTIVATED PROTEIN KINASE; OCTREOTIDE; PHOSPHOPROTEIN PHOSPHATASE; SOMATOSTATIN; SOMATOSTATIN RECEPTOR;

CONFERENCE PAPER; CYTOSTASIS; GROWTH INHIBITION; MOLECULAR CLONING; NEUROENDOCRINE TUMOR; PANCREAS TUMOR; RECEPTOR AFFINITY; STOMACH TUMOR;

FEMALE; HUMANS; MALE; NEUROENDOCRINE TUMORS; PANCREATIC NEOPLASMS; RECEPTORS, SOMATOSTATIN; SENSITIVITY AND SPECIFICITY; SOMATOSTATIN; STOMACH NEOPLASMS;

EID: 0032721914     PISSN: 11258055     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Reisine T, Bell GI. Molecular biology of somatostatin receptors. Endocrine Rev 1995;6:427-42.
2. Walsh J. Gastrointestinal hormones. In: Johnson LJ, editor. Physiology of the gastrointestinal tract. New York: Raven Press; 1994. p. 31-48.
3. Shen LP, Rutter WJ. Sequence of the human somatostatin I gene. Science 1984;224:168-71.
4. Naylor SL, Skaguchi AY, Shen LP, Bell GI, Rutter WJ, Shows TB. Polymorphic human somatostatin gene is located on chromosome 3. Proc Natl Acad Sci 1983;80:2686-9.
5. Buscail L, Esteve J-P, Saint Laurent N, Bertrand V, Reisine T, O'Carrol A-M, et al. Inhibition of cell proliferation by the somatostatin analogue RC-160 is mediated by somatostatin receptor subtypes SSTR2 and SSTR5 through different mechanisms. Proc Natl Acad Sci 1995;92:1580-4.
6. Chen L, Fitzpatrick VD, Vandlen RL, Tashjian AH. Both overlapping and distant signaling pathways for somatostatin receptor SSTR1 and SSTR2 in pituitary cells. J Biol Chem 1997;272:1866-72.
7. Bousquet C, Delesque N, Lopez F, Saint Laurent N, Esteve J-P, Bedees K, et al. sst2 somatostatin receptor mediates negative regulation of insulin receptor signaling through the tyrosine phosphatase SHP-1. J Biol Chem 1998;273:7099-106.
8. Florio T, Scorziello A, Fattore M, D'Alto V, Salzano S, Rossi G, et al. Somatostatin inhibits PC C13 thyroid cell proliferation through the modulation of phosphotyrosine phosphatase activity. J Biol Chem 1996;271:6129-36.
9. Cordelier P, Esteve J-P, Bousquet C, Delesque N, O'Carrol A-M, Schally AV, et al. Characterization of the antiproliferative signal mediated by the somatostatin receptor subtype sst5. Proc Natl Acad Sci 1997;921:580-4.
10. Todisco A, Tacheuchi Y, Yamada J, Sadoshima JI, Yamada T. Molecular mechanisms for somatostatin inhibition of c-fos gene expression. Am J Physiol 1997;272:G721-6.
11. Sharma K, Srikant CB. Induction of wild type p53, BAX, and acidic endonuclease during somatostatin-signaled apoptosis in MCF-7 human breast cancer cells. Int J Cancer 1998;76:259-66.
12. Glassmeier G, Strbing C, Riecken EO, Buhr G, Neuhaus P, Ahnert-Hilger G, et al. Electrophysiological properties of human carcinoid cells of the gut. Gastroenterology 1997;113:90-100.
13. 2+ currents in rat insulinoma 1046-38 cells. FEBS Lett 1998;425:137-40.
14. Lamberts SWJ, Krenning EP, Reubi JC. The role of somatostatin and its analogues in the diagnosis and treatment of tumors. Endoer Rev 1991;12:450-82.
15. Shaer J-C, Waser B, Mengod G, Reubi JC. Somatostatin receptor subtypes sst1, sst2, sst3 and sst5 expression in human pituitary, gastroentero-pancreatic and mammary tumour: comparison of mRNA analysis with receptor autoradiography. Int J Cancer 1997;70:530-7.
16. Faiss S, Scherübl H, Riecken EO. Wiedemmann B, Drug therapy in metastatic neuroendocrine tumors of the gastroenteropancreatic system. Rec Res Cancer Res 1994;142:193-207.
17. Scherübl H, Wiedemmann B, Riecken EO, Faiss S, Thomas F, Kommerell B, et al. Treatment of the carcinoid syndrome with a depot formulation of the somatostatin analogue lanreotide. Eur J Cancer 1994;6:1590-1.
18. Krenning EP, Kwekkebohm DJ, Oei HY, DeJong RJB, Dop FJ, Reubi JC, et al. Somatostatin-receptor scintigraphy in gastroenteropancreatic tumors. Ann NY Acad Sci 1994;733:416-24.
19. John M, Meyerhof W, Richter D, Waser B, Shaer J-C, Scherübel H, et al. Positive somatostatin receptor scintigraphy correlates with the presence of somatostatin in receptor subtype 2 and 5. Gut 1996;38:33-9.
20. Zimmer T, Ziegler K, Bäder M, Fett U, Hamm B, Riecken EO, et al. Localization of neuroendocrine tumors of the upper gastroin-testinal tract. Gut 1994;35:471-5.
21. Wiedenmann B, Jensen RT, Mignon M, Modlin CI, Skogseid B, Doherty G, et al. Preoperative diagnostic and surgical management of neuroendocrine gastroenteropancreatic tumors: general recommendations by a consensus workshop. World J Surg 1998;22:309-18.
22. Ahlman H, Tisell Le, Wangberg B, Nilsson O, Forssell-Aronsson E, Fjälling M. Somatostatin receptor imaging in patients with neuroendocrine tumors: preoperative and postoperative scintigraphy and intraoperative use of a scintillation detector. Sem Oncol 1994;21:21-8.
23. Jonas S, John M, Boese-Landgraf J, Häring R, Prevost G, Thomas F, et al. Somatostatin receptor subtypes in neuroendocrine tumour cell lines and tumour tissues. Langenbecks Arch Chir 1995;380:90-5.
24. Roth A, Kreienkamp H-J, Meyerhof W, Richter D. Phosphorylation of four amino acid residues in the carboxy terminus of the rat somatostatin receptor subtype 3 is crucial for its desensitization and intemalization. J Biol Chem 1997;272:23769-74.
25. Roostermann D, Roth A, Kreienkamp H-J, Richter D, Meyerhof WJ. Distinct agonist-mediated endocytosis of cloned rat somatostatin receptor subtypes expressed in insulinoma cells. Neuroendocrinol 1997;9;741-51.
26. Duncan JR, Stephenson MT, Wu HP, Anderson CJ, Indium-111-diethylenetriaminepentaacetic acid-octreotide is delivered in vivo to pancreatic, tumor cell, renal and hepatocyte lysosomes. Cancer Res 1997;57:659-71.
27. Krenning EP, Kooij PPM, Bajkker WH, Breeman WHE, Postema PTE, Kwekkebohm DJ, et al. Radiotherapy with radiolabeled somatostatin analogue [111-In-DTPA-D-Phel]-octreotide. Ann NY Acad Sci 1994;733:496-506.